Haloperidol Brochure Essay

In need of a medication brochure done(preferably color not b/w)by 11:59pm tonight. And I don’t quite have the time to complete one due to other assignments I have to complete

Pharmacology Brochure/Commercial Instructions Fall 2020 Haloperidol Brochure Essay

ORDER  HERE A PLAGIARISM-FREE PAPER HERE

Part 1 (Group of 4) Everyone must complete their own brochure
Utilize the Brochure Rubric posted under Program Resources on Blackboard. Use a brochure template that you can adjust to complete the objectives. You will be writing the information for the client so use language they can understand. Or, explain it in layman’s terms.  Haloperidol Brochure Essay
The brochure should be able to read correctly and each section should flow into the next.
On the back, put your name, course, Keiser University Clearwater. Do not use the Keiser logo! Your references will also go on the back page, written in APA format.
Include name of medication, both Brand and generic. Use some color and pictures to make it interesting.
Give a brief description of the medication and how it works.
Purpose of medication (uses), when and how to take medication, side effects and when to call the doctor. This is your client education section. Explain what they need to know. Include interactions and precautions. Don’t make a blanket statement like “Take medication as directed”. You need to direct them.
Dr Kaiser can help you with APA formatting if you can’t figure it out yourself.

Part 2 (Group of 4)
You will create a commercial of the medication that you have been assigned.
The video should be between 3-5 minutes.
Please upload your commercial to Youtube or another program that will allow you to share the video during class. Everyone must participate in the video.  Haloperidol Brochure Essay

Haloperidol is generally considered the drug of choice for in-hospital delirium management. We conducted a systematic review to evaluate the evidence for the efficacy and safety of haloperidol for the prevention and treatment of delirium in hospitalized patients. Methods: PubMed, Embase, Cumulative Index to Nursing and Allied Health (CINAHL), PsycINFO, and the Cochrane Library were systematically searched up to April 21, 2015. We included English full-text randomized controlled trials using haloperidol for the prevention or treatment of delirium in adult hospitalized patients reporting on delirium incidence, duration, or severity as primary outcome. Quality of evidence was graded. Meta-analysis was not conducted because of between-study heterogeneity. Results: Twelve studies met our inclusion criteria, four prevention and eight treatment trials. Methodological limitations decreased the graded quality of included studies. Results from placebo-controlled prevention studies suggest a haloperidol-induced protective effect for delirium in older patients scheduled for surgery: two studies reported a significant reduction in ICU delirium incidence and one study found a significant reduction in delirium severity and duration. Although placebo-controlled trials are missing, pharmacological treatment of established delirium reduced symptom severity.Haloperidol Brochure Essay  Haloperidol administration was not associated with treatment-limiting side-effects, but few studies used a systematic approach to identify adverse events. Conclusion: Although results on haloperidol for delirium management seem promising, current prevention trials lack external validity and treatment trials did not include a placebo arm on top of standard nonpharmacological care. We therefore conclude that the current use of haloperidol for in-hospital delirium is not based on robust and generalizable evidence. Haloperidol Brochure Essay